Avricore Historical Income Statement

AVCR Stock

CAD 0.04 0.01 10.00%

Historical analysis of Avricore Health income statement accounts such as Other Operating Expenses of 1.7 M, Total Operating Expenses of 5 M or Income Tax Expense of 50.5 K can show how well Avricore Health performed in making a profits. Evaluating Avricore Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Avricore Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Avricore Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avricore Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Avricore Income Statement Analysis

Avricore Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Avricore Health shareholders. The income statement also shows Avricore investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Avricore Health Income Statement Chart

At this time, Avricore Health's Total Operating Expenses is fairly stable compared to the past year. Income Tax Expense is likely to climb to about 50.5 K in 2025, whereas Other Operating Expenses is likely to drop slightly above 1.7 M in 2025.

Selling General Administrative Other Operating Expenses Total Operating Expenses Income Tax Expense

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Avricore Health. It is also known as Avricore Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Avricore Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Avricore Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2024	2025 (projected)
Depreciation And Amortization	18.0K	210.5K	221.0K
Income Tax Expense	38.4K	44.2K	50.5K

Depreciation And Amortization Income Tax Expense

Avricore Health income statement Correlations

	Selling General Administrative	Other Operating Expenses	Operating Income	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Ebit	Selling And Marketing Expenses	Research Development	Cost Of Revenue	Income Before Tax	Total Other Income Expense Net	Net Income From Continuing Ops	Net Interest Income	Interest Income	Discontinued Operations	Reconciled Depreciation
Selling General Administrative		0.8	-0.56	-0.58	0.75	-0.54	0.21	0.36	-0.13	0.46	0.46	-0.58	0.42	0.71	0.45	-0.48	-0.38	0.29	0.02	-0.48	0.36	0.45
Other Operating Expenses	0.8		-0.72	-0.68	0.68	-0.69	0.51	0.42	-0.26	0.38	0.35	-0.72	0.81	0.61	0.37	-0.65	-0.53	0.1	0.18	-0.2	0.13	0.41
Operating Income	-0.56	-0.72		0.99	-0.24	0.98	-0.5	-0.29	0.1	0.28	0.28	0.99	-0.7	-0.3	0.28	0.96	0.79	0.45	-0.05	0.26	0.24	-0.02
Ebitda	-0.58	-0.68	0.99		-0.22	0.97	-0.47	-0.2	0.07	0.3	0.3	0.99	-0.64	-0.29	0.31	0.94	0.76	0.43	-0.01	0.3	0.23	0.05
Total Operating Expenses	0.75	0.68	-0.24	-0.22		-0.24	0.19	0.51	-0.25	0.84	0.85	-0.28	0.52	0.69	0.83	-0.2	-0.21	0.44	0.15	-0.36	0.4	0.79
Net Income	-0.54	-0.69	0.98	0.97	-0.24		-0.42	-0.38	0.07	0.27	0.27	0.99	-0.65	-0.33	0.28	0.99	0.88	0.47	-0.01	0.33	0.24	-0.09
Income Tax Expense	0.21	0.51	-0.5	-0.47	0.19	-0.42		-0.15	-0.1	-0.05	-0.05	-0.46	0.68	0.15	-0.05	-0.4	-0.15	-0.02	0.09	0.09	-0.03	-0.17
Depreciation And Amortization	0.36	0.42	-0.29	-0.2	0.51	-0.38	-0.15		-0.03	0.37	0.34	-0.33	0.25	0.6	0.38	-0.36	-0.51	0.06	-0.05	-0.45	0.32	0.87
Interest Expense	-0.13	-0.26	0.1	0.07	-0.25	0.07	-0.1	-0.03		-0.22	-0.22	0.07	-0.28	0.2	-0.23	0.08	0.1	0.27	-0.99	-0.41	0.37	-0.18
Total Revenue	0.46	0.38	0.28	0.3	0.84	0.27	-0.05	0.37	-0.22		1.0	0.24	0.2	0.58	1.0	0.3	0.22	0.72	0.15	-0.16	0.55	0.75
Gross Profit	0.46	0.35	0.28	0.3	0.85	0.27	-0.05	0.34	-0.22	1.0		0.25	0.19	0.56	0.99	0.31	0.22	0.7	0.15	-0.18	0.53	0.74
Ebit	-0.58	-0.72	0.99	0.99	-0.28	0.99	-0.46	-0.33	0.07	0.24	0.25		-0.68	-0.34	0.25	0.96	0.81	0.41	-0.01	0.32	0.19	-0.07
Selling And Marketing Expenses	0.42	0.81	-0.7	-0.64	0.52	-0.65	0.68	0.25	-0.28	0.2	0.19	-0.68		0.33	0.19	-0.65	-0.48	-0.17	0.24	0.01	-0.19	0.22
Research Development	0.71	0.61	-0.3	-0.29	0.69	-0.33	0.15	0.6	0.2	0.58	0.56	-0.34	0.33		0.58	-0.27	-0.24	0.58	-0.33	-0.76	0.73	0.64
Cost Of Revenue	0.45	0.37	0.28	0.31	0.83	0.28	-0.05	0.38	-0.23	1.0	0.99	0.25	0.19	0.58		0.3	0.22	0.72	0.15	-0.14	0.56	0.76
Income Before Tax	-0.48	-0.65	0.96	0.94	-0.2	0.99	-0.4	-0.36	0.08	0.3	0.31	0.96	-0.65	-0.27	0.3		0.92	0.51	-0.03	0.29	0.29	-0.06
Total Other Income Expense Net	-0.38	-0.53	0.79	0.76	-0.21	0.88	-0.15	-0.51	0.1	0.22	0.22	0.81	-0.48	-0.24	0.22	0.92		0.52	-0.04	0.31	0.32	-0.22
Net Income From Continuing Ops	0.29	0.1	0.45	0.43	0.44	0.47	-0.02	0.06	0.27	0.72	0.7	0.41	-0.17	0.58	0.72	0.51	0.52		-0.33	-0.29	0.89	0.36
Net Interest Income	0.02	0.18	-0.05	-0.01	0.15	-0.01	0.09	-0.05	-0.99	0.15	0.15	-0.01	0.24	-0.33	0.15	-0.03	-0.04	-0.33		0.54	-0.46	0.08
Interest Income	-0.48	-0.2	0.26	0.3	-0.36	0.33	0.09	-0.45	-0.41	-0.16	-0.18	0.32	0.01	-0.76	-0.14	0.29	0.31	-0.29	0.54		-0.56	-0.4
Discontinued Operations	0.36	0.13	0.24	0.23	0.4	0.24	-0.03	0.32	0.37	0.55	0.53	0.19	-0.19	0.73	0.56	0.29	0.32	0.89	-0.46	-0.56		0.46
Reconciled Depreciation	0.45	0.41	-0.02	0.05	0.79	-0.09	-0.17	0.87	-0.18	0.75	0.74	-0.07	0.22	0.64	0.76	-0.06	-0.22	0.36	0.08	-0.4	0.46

Click cells to compare fundamentals

Avricore Health Account Relationship Matchups

Avricore Health income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Selling General Administrative	845.6K	1.7M	1.0M	1.8M	2.1M	1.2M
Other Operating Expenses	1.6M	886.3K	1.9M	2.6M	3.0M	1.7M
Operating Income	(859.2K)	(1.7M)	(809.9K)	(687.2K)	(618.5K)	(649.4K)
Ebitda	(1.4M)	(859.2K)	(1.7M)	(626.8K)	(564.1K)	(592.3K)
Total Operating Expenses	870.7K	1.8M	1.3M	4.2M	4.8M	5.0M
Net Income	(1.2M)	(1.7M)	(818.2K)	(701.2K)	(631.1K)	(662.6K)
Income Tax Expense	540.0	196.6K	40.4K	38.4K	44.2K	50.5K
Depreciation And Amortization	180.5K	118.5K	18.0K	183.0K	210.5K	221.0K
Total Revenue	33.0K	122.8K	1.8M	3.5M	4.0M	4.2M
Gross Profit	17.5K	30.5K	456.8K	1.2M	1.4M	1.5M
Ebit	(1.6M)	(977.7K)	(1.7M)	(809.9K)	(728.9K)	(765.3K)
Selling And Marketing Expenses	472.5K	44.7K	2.3K	176.0K	202.4K	335.9K
Cost Of Revenue	15.6K	92.3K	1.3M	2.3M	2.6M	2.8M
Income Before Tax	(1.2M)	(1.7M)	(818.2K)	(701.2K)	(631.1K)	(662.6K)
Total Other Income Expense Net	(155.9K)	75.3K	(8.4K)	(11.2K)	(10.1K)	(10.6K)
Net Income From Continuing Ops	(1.2M)	(1.7M)	(818.2K)	(701.2K)	(806.4K)	(846.7K)
Net Income Applicable To Common Shares	(4.1M)	(2.1M)	(1.2M)	(1.7M)	(2.0M)	(2.1M)
Net Interest Income	(164.9K)	(44.7K)	2.7K	(2.7K)	(2.5K)	(2.6K)
Reconciled Depreciation	68.3K	18.0K	183.0K	420.1K	483.1K	507.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avricore Historical Income Statement

About Avricore Income Statement Analysis

Avricore Health Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Avricore Health income statement Correlations

Avricore Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Avricore Health income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Avricore Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Ebitda	+ 0.99	Operating Income
Ebit	+ 0.99	Operating Income
Ebit	+ 0.99	Ebitda
Ebit	+ 0.99	Net Income

Net Interest Income	- 0.99	Interest Expense
Interest Income	- 0.76	Research Development
Ebit	- 0.72	Other Operating Expenses
Operating Income	- 0.72	Other Operating Expenses
Selling And Marketing Expenses	- 0.7	Operating Income
Net Income	- 0.69	Other Operating Expenses